Logos Global Management LP Deciphera Pharmaceuticals, Inc. Transaction History

Logos Global Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $14.2 Million - $68.7 Million	-1,850,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $19.8 Million - $27.9 Million	750,000 Added 68.18%	1,850,000 $62.9 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $34 Million - $49.8 Million	1,038,000 Added 1674.19%	1,100,000 $40.3 Million
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $2.5 Million - $3.52 Million	62,000 New	62,000 $2.78 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.